Upper airway considerations in hereditary angioedema

Current Opinion in Allergy and Clinical Immunology
Efimia Papadopoulou-Alataki

Abstract

The purpose of the present review is to outline the clinical aspects and management of the upper airway involvement in the patients suffering from hereditary angioedema. Molecular mechanisms of hereditary angioedema reviewed in the literature conclude that it is an autosomal dominant disorder, characterized by the deficiency of C1 inhibitor due to mutations of its gene (SERPING). Hereditary angioedema manifests as episodes of localized swelling in any site of the body from skin, gastrointestinal tract to the upper airway, where it is severe and life-threatening. The age of onset, frequency of attacks and the factors triggering upper airway swelling in hereditary angioedema are variable among different patients. Acute laryngeal edema should be managed in emergency with monitoring of airway patency. To avoid airway obstruction, therapy should begin early either with current treatment (C1 inhibitor concentrate) or with new drugs developed recently. In patients with recurrent upper airway swelling attacks, long-term prophylaxis is recommended. The use of old and new treatment in acute attacks as well as in prophylaxis (long and short-term) has changed the outcome of patients with hereditary angioedema who present upper airway swell...Continue Reading

References

Sep 10, 2004·The Journal of Allergy and Clinical Immunology·Angelo AgostoniLorenza Zingale
Feb 24, 2006·The American Journal of Medicine·Konrad BorkJochen Hardt
Jun 15, 2007·The Journal of Allergy and Clinical Immunology·Lynda SchneiderTess Schmalbach
Aug 29, 2007·Pediatrics·Henriette FarkasTom Bowen
Sep 1, 2007·The Journal of Allergy and Clinical Immunology·Henriette FarkasLilian Varga
Sep 5, 2007·Molecular Immunology·Marco CicardiDaniela Lambertenghi Deliliers
Jan 22, 2008·The Journal of Allergy and Clinical Immunology·Michael M Frank, Haixiang Jiang
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·I Leonard Bernstein
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Alvin E Davis
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Bruce L Zuraw
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Aleena BanerjiAlbert L Sheffer
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Michael M Frank
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Tom BowenZhi Yu Xiang
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jonathan A Bernstein
Apr 1, 2008·The American Journal of Medicine·Viviana M Temiño, R Stokes Peebles
Apr 16, 2008·Clinical and Molecular Allergy : CMA·Alvin E Davis
May 20, 2008·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Rafael NaglerZvi Laster
Jun 7, 2008·International Archives of Allergy and Immunology·Efimia Papadopoulou-AlatakiGeorgios Varlamis
Jul 29, 2008·Journal of Immunological Methods·Ineke G A Wagenaar-BosS Marieke van Ham
Sep 5, 2008·The New England Journal of Medicine·Bruce L Zuraw
Dec 20, 2008·Drugs·Tolly G Epstein, Jonathan A Bernstein
Jan 24, 2009·Trends in Molecular Medicine·Massimo CugnoMarco Cicardi
Feb 10, 2009·The Journal of Allergy and Clinical Immunology·Suna BüyüköztürkZ Oya Uyguner
Feb 12, 2009·Therapeutics and Clinical Risk Management·Michael J PremattaTimothy J Craig
Mar 7, 2009·European Journal of Dermatology : EJD·Anette BygumCarsten Sauer Mikkelsen
May 30, 2009·The Journal of Allergy and Clinical Immunology·Konrad BorkPetra Staubach
Aug 27, 2009·Human Immunology·Matthaios SpeletasAnastasios E Germenis

❮ Previous
Next ❯

Citations

Dec 1, 2011·Current Allergy and Asthma Reports·Monali Vasekar, Timothy J Craig
Jul 30, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Henriette Farkas
Nov 8, 2012·International Journal of Emergency Medicine·Jonathan A Bernstein, Joseph Moellman
Apr 5, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Ying-Yang XuHong-Yu Zhang
Jun 14, 2012·Postgraduate Medicine·Jonathan A Bernstein, Joseph J Moellman
Jan 13, 2015·Annals of Medicine·Maria PedrosaUNKNOWN Spanish Group for the Study of Bradykinin-Mediated Angioedema (SGBA) and the Spanish Committee of Cutaneous Allergy (CCA)
Apr 4, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Albert L ShefferWilliam E Pullman
Aug 15, 2014·Frontiers in Pediatrics·Milos JesenakEva Babusikova
Dec 22, 2011·American Journal of Rhinology & Allergy·Bruce L Zuraw, Sandra C Christiansen
Dec 22, 2011·American Journal of Rhinology & Allergy·Sandra C Christiansen, Bruce L Zuraw
Jan 7, 2017·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Bernard FloccardUNKNOWN French Reference Centre for Angioedema (CREAK)
Aug 19, 2017·Deutsches Ärzteblatt International·Janina HahnJens Greve

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.